Pretreatment AKR1B10 expression predicts the risk of hepatocellular carcinoma development after hepatitis C virus eradication

doi:10.3748/wjg.v22.i33.7569

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 22, Issue 33

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8086)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-3) series.

Item

Count

PDF

392

WORD

268

HTML

4006

Figures (1-5)

208

Tables (1-3)

218

Sum=5092

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1290

Download

1704

Sum=2994

Sep 7, 2016 (publication date) through Jul 19, 2024

Times Cited of This Article

Times Cited (14)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Sep 7, 2016; 22(33): 7569-7578
Published online Sep 7, 2016. doi: 10.3748/wjg.v22.i33.7569

Full Size Figure Download Figure

Figure 2 Representative AKR1B10 immunohistochemical staining of specimens. Normal liver tissue (A, B) and tissue from patients with chronic hepatitis C (C-F). Hematoxylin and eosin staining (A, C, E) and AKR1B10 immunostaining (B, D, F). Positive control, bile-duct epithelium; original magnification × 40.

Citation: Murata A, Genda T, Ichida T, Amano N, Sato S, Tsuzura H, Sato S, Narita Y, Kanemitsu Y, Shimada Y, Hirano K, Iijima K, Wada R, Nagahara A, Watanabe S. Pretreatment AKR1B10 expression predicts the risk of hepatocellular carcinoma development after hepatitis C virus eradication. World J Gastroenterol 2016; 22(33): 7569-7578
URL: https://www.wjgnet.com/1007-9327/full/v22/i33/7569.htm
DOI: https://dx.doi.org/10.3748/wjg.v22.i33.7569